129 related articles for article (PubMed ID: 35350239)
1. Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma.
Li YR; Zong RQ; Zhang HY; Meng XY; Wu FX
Front Genet; 2022; 13():861096. PubMed ID: 35350239
[No Abstract] [Full Text] [Related]
2. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
3. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
Guo B; Wu S; Zhu X; Zhang L; Deng J; Li F; Wang Y; Zhang S; Wu R; Lu J; Zhou Y
EMBO J; 2020 Jan; 39(1):e102190. PubMed ID: 31755573
[TBL] [Abstract][Full Text] [Related]
4. Long Intergenic Non-Protein Coding RNA 665 Regulates Viability, Apoptosis, and Autophagy via the MiR-186-5p/MAP4K3 Axis in Hepatocellular Carcinoma.
Shan Y; Li P
Yonsei Med J; 2019 Sep; 60(9):842-853. PubMed ID: 31433582
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00665 is a diagnostic biomarker that enhances cell proliferation and migration in hepatocellular carcinoma.
Li Z; Yuan J; Yan Z; Liu X; Liu J
Int J Clin Exp Pathol; 2023; 16(11):332-343. PubMed ID: 38059173
[TBL] [Abstract][Full Text] [Related]
6. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
8. LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.
Zhong C; Xie Z; Shen J; Jia Y; Duan S
Cells; 2022 May; 11(9):. PubMed ID: 35563845
[TBL] [Abstract][Full Text] [Related]
9. LINC00665 target let-7i/HMGA1 promotes the proliferation and invasion of hepatoma cells.
Zhang BC; Ma SY; Zhu P; Zhu LY; Zhao XX; Pu C
Mutat Res; 2024; 828():111852. PubMed ID: 38368811
[TBL] [Abstract][Full Text] [Related]
10. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
He H; Wu G; Li W; Cao Y; Liu Y
Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
[TBL] [Abstract][Full Text] [Related]
11. LINC00665 Targets miR-214-3p/MAPK1 Axis to Accelerate Hepatocellular Carcinoma Growth and Warburg Effect.
Wan H; Tian Y; Zhao J; Su X
J Oncol; 2021; 2021():9046798. PubMed ID: 34804162
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
Front Oncol; 2020; 10():780. PubMed ID: 32587825
[No Abstract] [Full Text] [Related]
13. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
Wang H; Wang L; Zhang S; Xu Z; Zhang G
Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
15. LINC00665 facilitates the progression of osteosarcoma via sponging miR-3619-5p.
Zhang DW; Gu GQ; Chen XY; Zha GC; Yuan Z; Wu Y
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9852-9859. PubMed ID: 33090388
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
Yang X; Qu K; Tao J; Yin G; Han S; Liu Q; Sun H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1807-1814. PubMed ID: 29175329
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
18. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
Abuduer M; A EZG
Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT.
Zhou JL; Zou L; Zhu T
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3097-3104. PubMed ID: 32271427
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
